期刊文献+

缺血性脑卒中神经保护治疗的研究进展 被引量:12

Advance in neuroprotective therapy for ischemic stroke
下载PDF
导出
摘要 脑卒中是一种严重影响人类生命和生活质量的中枢神经系统疾病,全球死亡率排序位列第2位。目前缺血性脑卒中的临床治疗策略主要是静脉溶栓及机械取栓疗法,然而,这些治疗方法不能有效防止缺血引起的脑组织损伤与功能障碍,需要寻找能够有效防止脑缺血损伤与脑缺血-再灌注损伤的神经保护疗法。本文回顾了近年防治缺血性脑卒中后神经功能损伤药物,包括离子通道阻断剂、抗氧化剂、抗炎药物、凋亡抑制剂等的研究进展,对这些药物的特点和优劣进行分析,并总结了非药物神经保护疗法。 Stroke is a central nervous system disease that seriously affects the quality of life of the victims,with the second highest mortality among all the diseases in the world.At present,the main clinical treatment strategies for acute ischemic stroke are intravenous thrombolysis and mechanical thrombectomy,whereas these strategies do not protect patients from ischemia injury and functional disorder.Therefore,it is necessary to find neuroprotective methods to ameliorate ischemic injury and ischemic/reperfusion injury.This review summed up the current studies on the drugs which prevent and treat neurologic impairment after ischemic stroke,including ion channel blocker,antioxidant,anti-inflammatory agent,anti-apoptotic agent,analyzed the characteristics and advantages and disadvantages,and summarized several non-drug neuroprotective therapies.
作者 李翯 骆银 杨鹏飞 刘建民 LI He;LUO Yin;YANG Peng-fei;LIU Jian-min(Stroke Center,Changhai Hospital,Navy Medical University(Second Military Medical University),Shanghai 200433,China;The Second Student Team,Graduate School,Navy Medical University(Second Military Medical University),Shanghai 200433,China)
出处 《第二军医大学学报》 CAS CSCD 北大核心 2018年第9期1040-1046,共7页 Academic Journal of Second Military Medical University
基金 上海市卫生系统优秀人才培养计划(2017YQ034) 上海市浦江人才计划项目(16PJD003)~~
关键词 缺血性脑卒中 神经保护 再灌注损伤 抗氧化剂 ischemic stroke neuroprotection reperfusion injury antioxidants
  • 相关文献

参考文献3

二级参考文献42

  • 1Reuter S, Gupta S C, ,Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: How are they linked? [J]. Free Radic Biol Med,2010,49(ll):1603-1616. DOl:10.1016/j.freeradbiomed. 2010.09.006.
  • 2Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer[J]. Mutat Res, 2001,477(1-2):7-21. DOI: 10.1016/S0027-5107(01)00091-4.
  • 3Stor'z P. Reactive oxygen species in tumor progression[J]. Front Biosci,2005,10:1881-1896. DOI:10.2741/1667.
  • 4Spore MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context[J]. Nat Rev Cancer,2012,12(8):564-571. DOl:10.1038/nrc3278.
  • 5Moi P, Chan K, Asunis I, et al. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-1ike basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region[J]. Proc Natl Acad Sci U S A, 1994,91(21):9926-9930. DOI:10.1073/pnas.91.21.9926.
  • 6Cullinan SB, Gordan JD, Jin J, et al. The Keapl-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keapl ligase [J]. Mol Cell Biol,2004,24 (19):8477-8486. DOI: 10.1128/MCB.24.19.8477-8486.20.
  • 7Tong KI, Balasundaram P, Akira K, et al. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response[J]. Mol Cell Biol,2007,27(21):7511- 7521. DOI:10.1128/MCB.00753-07.
  • 8Namani A, Li Y, Wang X J, et al. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer [J]. Biochim Biophys Acta,2014,1843(9):1875-1885. DOI:10.1016/j. bbamcr.2014.05.003.
  • 9Ga6n-G6mez I, Wei Y, Yang H, et al. Oncogenic functions of the transcription factor Nrf2[J]. Free Radic Biol Med,2013,65: 750-764. DOI: 10.1016/j.freeradbiomed.2013.06.041.
  • 10Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2-an update [J]. Free Radic Biol Med,2014,66:36-44. DOI:10.1016/j.free radbiomed. 2013.02.008.

共引文献42

同被引文献114

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部